Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Shin Poong Pharmaceutical Co., Ltd. (002870)
Market Open
15 Oct, 06:30 AM
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
963.
00
-100
-9.4073%
₩
32.06B
Market Cap
-
P/E Ratio
20%
Div Yield
343,247
Volume
0
Eps
₩
1,063
Previous Close
Watching
Watch
Add Transaction
Day Range
963
1,066
Year Range
664
1,471
Want to track
002870
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Shin Poong Pharmaceutical Co., Ltd. (002870) Statistics
Valuation metrics
Market Cap
32.06B
Enterprise value
23.1B
Trailing P/E (ttm)
3.69
Forward P/E
-
PEG ratio
0
Price/Sales (ttm)
1.29
Price/Book (mrq)
0.39
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
-8.84
Overview
Shares outstanding
27.71M
Float
15.78M
Shares short
-
% Held by insiders
0.34%
% Held by institutions
0%
Average volume (10 days)
170.05K
Average volume (90 days)
205.92K
Price summary
52-Week low
664
52-Week high
1,471
Beta
0.33
50-Day moving average
1,090
200-Day moving average
1,050.68
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
110
Trailing annual dividend yield
0.0951%
5-Year annual dividend yield
3.21%
Payout ratio
-
Dividend Date
20 Aug 2026
Ex-Dividend Date
4 Aug 2026
Last split factor
10:1
Last split Date
19 Apr 2017
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.35%
Operating margin
-0.09%
Operational effectiveness
Return on assets
0.1%
Return on equity
0.11%
Income Statement
Revenue (ttm)
24.23B
Revenue per share (ttm)
897.5
Quarterly revenue growth (yoy)
-0.06%
Gross profit (ttm)
4.21B
EBITDA
-1.19B
Net income to common (ttm)
2B
Diluted EPS (ttm)
313.18
Quarterly earnings growth (yoy)
-0.06%
Balance Sheet
Total cash (mrq)
36.68B
Total cash per share (mrq)
1,167.7
Total debt (mrq)
933.36M
Total Debt/Equity (mrq)
0
Current ratio (mrq)
33.43%
Book value per share (mrq)
2,935.85
Cash Flow
Cash flow statement
2.66B
Levered free cash flow (LFCF)
1.84B